BACK, ZPTA and ABVC Are Among Premarket Gainers
Seeking AlphaApr 24 09:12 ET
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply in today's pre-market trading following first-quarter results.Tesla posted weaker-than-expected earnings and sales results for its first quarter on Tue
BenzingaApr 24 08:09 ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers180 Life Sciences (NASDAQ:ATNF) shares moved upwards by 7.4% to $2.04 during Tuesday's after-market session. The market value of their outstanding shares is at $1.7 million. ABVC BioPharma (NAS
BenzingaApr 23 16:31 ET
AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
FREMONT, CA, April 18, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ:ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology,
GlobeNewswireApr 18 09:25 ET
ABVC BioPharma Enters Licensing Agreement With OncoX For Commercialization Of BLEX 404
RTTNewsApr 17 09:48 ET
Express News | ABVC Biopharma Inc - to Receive $12.5M License Fee From Oncox
Moomoo 24/7Apr 17 09:03 ET
Express News | ABVC Biopharma Executes a Global Licensing Definitive Agreement for the Treatment of Nsclc, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
Moomoo 24/7Apr 17 09:00 ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersRallybio (NASDAQ:RLYB) shares rose 31.9% to $2.15 during Wednesday's after-market session. The company's market cap stands at $81.2 million. Vera Therapeutics (NASDAQ:VERA) shares increased by
BenzingaApr 10 16:31 ET
ABVC Biopharma Stock Climbs on Deal for Its Oncology/hematology Products
Seeking AlphaApr 10 09:23 ET
Market-Moving News for April 10th
ADIL: 108% | Adial Pharmaceuticals shares are trading higher after the company announced the publication of a peer-reviewed article highlighting the clinical results, strong safety profile, and high c
BenzingaApr 10 08:39 ET
12 Health Care Stocks Moving In Monday's After-Market Session
GainersOpGen (NASDAQ:OPGN) shares moved upwards by 24.0% to $0.74 during Monday's after-market session. The market value of their outstanding shares is at $7.4 million. Galecto (NASDAQ:GLTO) shares in
BenzingaApr 1 16:31 ET
VERI, CHEK and MESO Are Among Pre Market Gainers
Seeking AlphaMar 27 08:24 ET
NeuBase Therapeutics, ABVC BioPharma, Stoke Therapeutics Among Healthcare Movers
Seeking AlphaMar 26 10:00 ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersStoke Therapeutics (NASDAQ:STOK) stock increased by 80.2% to $11.71 during Tuesday's pre-market session. The market value of their outstanding shares is at $522.8 million. As per the press rele
BenzingaMar 26 09:05 ET
Express News | ABVC BioPharma Enters Global Licensing Deal With ForSeeCon Eye Corporation For Vitargus; Deal Includes Licensing Income Of $33.5M And Royalties Up To $60M
Moomoo 24/7Mar 26 08:32 ET
AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars
FREMONT, CA, March 21, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ:ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in
GlobeNewswireMar 21 08:30 ET
ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine
ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, proudly announced today that its CEO, Dr. Uttam Patil, was selected as one of the Top 10 CEOs in Taiwan 2024 by CEO Insights Asia Magazine.
GlobeNewswireMar 19 08:30 ET
ABVC BioPharma GAAP EPS of -$2.43, Revenue of $0.15M
Seeking AlphaMar 14 14:04 ET
ABVC BioPharma 2023 Loss/Shr $2.43 >ABVC
ABVC BioPharma 2023 Loss/Shr $2.43 >ABVC
Dow JonesMar 14 09:32 ET
Press Release: ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
FREMONT, CA, March 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a biotechnology company specializing in botanically based solutions that deliver high efficacy and low toxicity to improve health outcomes, announced its 2023 annual financial and operating results.
Dow JonesMar 14 09:30 ET
No Data
No Data